Most recent by Barbara Kienzle, BSN, RN
Patients with rheumatoid arthritis, PsA, AS ‘stuck in a cycle of long-term opioid use’
Patients with rheumatic diseases demonstrate a high reliance on opioids around the time of diagnosis, and significant numbers of patients were not on appropriate treatment in the year afterward, according to data in Clinical Rheumatology.
SLE-DAS remission, low disease activity show promise as treat-to-target measures
Remission and low disease activity can discriminate between patients taking active drug vs. placebo in clinical trials and are linked to health-related quality of life, according to data in Arthritis Care & Research.
Black women with lupus who experience racial discrimination have worse inflammation
Among Black women with lupus, those who experience racial discrimination demonstrate increased C-reactive protein and worse inflammation, according to data published in Brain, Behavior and Immunity.
Patients with lupus at highest risk for ischemic heart disease 6 to 9 years post-diagnosis
Patients with systemic lupus erythematosus demonstrate a higher risk for ischemia heart disease, with the biggest danger manifesting 6 to 9 years after diagnosis, according to data published in BMC Rheumatology.
TMJ involvement, dentofacial deformity ‘frequent complications’ of juvenile arthritis
Approximately 30% of patients with juvenile idiopathic arthritis develop temporomandibular joint involvement before transitioning to adult care, according to data published in Arthritis & Rheumatology.
Family history of autoimmune disease a risk factor for juvenile idiopathic arthritis
Family history of autoimmune disease is a risk factor for developing of juvenile idiopathic arthritis, although it does not impact disease severity or course, according to data published in Pediatric Rheumatology.
Positive COVID-19 vaccine responses persist in patients with RA receiving rituximab
In patients with rheumatoid arthritis receiving rituximab, a positive humoral response following COVID-19 vaccination persists regardless of continued rituximab infusion, according to data published in Rheumatology.
Positive COVID-19 vaccine responses persist in patients with RA receiving rituximab
In patients with rheumatoid arthritis receiving rituximab, a positive humoral response following COVID-19 vaccination persists regardless of continued rituximab infusion, according to data published in Rheumatology.
Kawasaki disease incidence curbed by COVID-19 lockdown behaviors
Cases of Kawasaki disease dropped 28% during the COVID-19 pandemic and remained low following implementation of prevention efforts, including mask mandates and school closures, according to data published in JAMA Network Open.
Children who experience adverse childhood events may have worse chronic pain symptoms
Children with chronic pain or rheumatic disease who experience adverse childhood events may be at a greater risk for worse symptoms and “functional disability,” according to data published in Pediatric Rheumatology.